Work

Cancer Risk With Advanced Therapies in Patients With Inflammatory Bowel Diseases: An Administrative Claims–Based Study

Year: 2026

Type: article

Study design: Observational Study

Source: Clinical Gastroenterology and Hepatology

DOI: 10.1016/j.cgh.2026.08.003

Authors: Dhruv Ahuja, Kuan-Hung Yeh, Soo-kyung Park, Yuchen Qi, Sagar B. Patel, Shane W. Goodwin, Sudheer K. Vuyyuru, Talha A. Malik, Guilherme Piovezani Ramos, Anna Silverman, Namrata Singh, Ola Olen, Ashwin N. Ananthakrishnan, Vipul Jairath, Ronghui Xu, Siddharth Singh

Institutions: University of California San Diego, Kangbuk Samsung Hospital, Sungkyunkwan University, Western University, Mayo Clinic in Arizona, University of Washington, Karolinska Institutet, Sachs' Children and Youth Hospital, Harvard University, Massachusetts General Hospital

Language: English

Topic: Inflammatory Bowel Disease

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Pfizer, Crohn's and Colitis Foundation, Karolinska Institutet, National Institutes of Health, National Institute on Aging, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Arthritis and Musculoskeletal and Skin Diseases

Awards: G3375283054, Impact of rheumatoid arthritis on survival in older adults with cancer, Comparative effectiveness research in Hispanic patients with inflammatory bowel diseases, Improving shared decision-making around the use of disease modifying anti-rheumatic drugs in patients with rheumatoid arthritis and cancer

OpenAlex ID: W7203608932

FWCI:

Cites: 31

Cited by:

Related to: 10